Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies
Dafna D. Gladman(Toronto Western Hospital), Philip J. Mease(Providence College), Maurizio Cutolo(Ospedale Policlinico San Martino), Nikolay Delev(Bristol-Myers Squibb (Sweden)), Juan J. Gómez‐Reino(Hospital Clínico Universitario de Valencia), Georg Schett(Karolinska University Hospital), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Arthur Kavanaugh(University of California System), C. Birbara(University of Massachusetts Chan Medical School), Lichen Teng(Harbin Medical University), B. Guérette, J. Wollenhaupt(Schön Klinik Hamburg Eilbek), Éric Lespessailles(Université d'Orléans)
Cited by 38
Related Papers
The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity
|Arthritis Care & Research|2010|3.9k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
|The Lancet|2000|1.5k